Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2019
Generic drug approvals soar, but patients still go without
19 November 2019 - Brand name makers’ patent action limits release of the lower-price medicines, hindering cost-control efforts. ...
Posted by Michael Wonder on 19 Nov 2019
Epilepsy sufferer says victims of PHARMAC drug switch should be compensated
19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC backs down on epilepsy drug brand switch
15 November 2019 - PHARMAC has backed down on a controversial drug brand switch affecting patients with epilepsy and mental ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC to widen access to the exceptional circumstances process for lamotrigine
15 November 2019 - Patients taking lamotrigine who have concerns about the change can talk with their doctor about remaining ...
Posted by Michael Wonder on 13 Nov 2019
Epilepsy NZ calls for halt to drug switch following deaths of three people
13 November 2019 - Epilepsy New Zealand is urging authorities to immediately halt a drug switch following the death of ...
Posted by Michael Wonder on 12 Nov 2019
Three deaths following epilepsy drug brand switch
12 November 2019 - Three deaths have been reported to the Centre for Adverse Reactions Monitoring after PHARMAC forced patients ...
Posted by Michael Wonder on 24 Oct 2019
Mother fears daughter's death linked to PHARMAC's epilepsy drug switch
25 October 2019 - A woman who fears her daughter's death is linked to a change in her epilepsy medicine is ...
Posted by Michael Wonder on 17 Oct 2019
Have FDA actions to ease generic drug shortages taken effect yet?
16 October 2019 - On Wednesday, the FDA said fiscal year 2018 saw a record number of generic drug approvals. ...
Posted by Michael Wonder on 16 Oct 2019
Statement on continued progress enhancing patient access to high-quality, low-cost generic drugs
16 October 2019 - FDA generic drug approvals reach record high in fiscal year 2019. ...
Posted by Michael Wonder on 14 Oct 2019
FDA bid to bolster generic competition and combat shortages isn’t working — yet
14 October 2019 - Although the FDA has maintained that additional generic approvals should promote competition and alleviate shortages, the ...
Posted by Michael Wonder on 12 Oct 2019
Have FDA’s generic approvals helped with competition? Researchers say too early to tell
11 October 2019 - Amid increasing abbreviated new drug application approvals, efforts by the US FDA to promote generic drug development ...
Posted by Michael Wonder on 09 Oct 2019
California is first US state to ban pay-for-delay deals
8 October 2019 - California has become the first US state to ban the pharma industry practice of paying rivals ...
Posted by Michael Wonder on 24 Sep 2019
Drug firms admit to colluding in order to keep prices up
20 September 2019 - Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up. ...
Posted by Michael Wonder on 16 Sep 2019
FDA seeks input on product-specific guidances to facilitate generic drug development
16 September 2019 - Today, FDA published 53 product-specific guidances (PSGs) – 34 new guidances and 19 revised guidances, including ...
Posted by Michael Wonder on 13 Sep 2019
Taranaki man fearful drug funding change will bring back a life of seizures
13 September 2019 - For three years now a normal life has cost Nick Coulton $10 every three months. From ...